Pubblicazioni Scientifiche

1. Cavallini G, Cristina Magli M, Crippa A, Pia Ferraretti A, Gianaroli L. Reduction in sperm aneuploidy levels in severe oligoasthenoteratospermic patients after medical therapy: a preliminary report. Asian J Androl. 2012 Apr 30. doi: 10.1038/aja.2012.23. [Epub ahead of print] PubMed PMID: 22543677.

2. Cavallini G, Biagiotti G, Lo Giudice C. Association Between Peyronie’s Disease and Low Serum Testosterone Levels: Detection and Therapeutic Considerations. J Androl. 2011 Jun 30. [Epub ahead of print] PubMed PMID: 21719695.

3. Cavallini G, Beretta G, Biagiotti G. Preliminary study of letrozole use for improving spermatogenesis in non-obstructive azoospermia patients with normal serum FSH. Asian J Androl. 2011 Jun 27. doi: 10.1038/aja.2011.44. [Epub ahead of print] PubMed PMID: 21706040.

4. Cavallini G, Cristina Magli M, Crippa A, Resta S, Vitali G, Pia Ferraretti A, Gianaroli L. The number of spermatozoa collected with testicular sperm extraction is a novel predictor of intracytoplasmic sperm injection outcome in non-obstructive azoospermic patients. Asian J Androl. 2011 Mar;13(2):312-6. Epub 2011 Jan 17. PubMed PMID: 21240295.

5. Gianaroli L, Magli MC, Cavallini G, Crippa A, Capoti A, Resta S, Robles F, Ferraretti AP. Predicting aneuploidy in human oocytes: key factors which affect the meiotic process. Hum Reprod. 2010 Sep;25(9):2374-86. Epub 2010 Jul 8. PubMed PMID: 20616356; PubMed Central PMCID: PMC2922997.

6. Cavallini G, Crippa A, Magli MC, Cavallini N, Ferraretti AP, Gianaroli L. A study to sustain the hypothesis of the multiple genesis of oligoasthenoteratospermia in human idiopathic infertile males. Biol Reprod. 2008 Oct;79(4):667-73. Epub 2008 Jun 18. PubMed PMID: 18562708.

7. Cavallini G, Caracciolo S. Pilot study to determine improvements in subjective penile morphology and personal relationships following a Nesbit plication procedure for men with congenital penile curvature. Asian J Androl. 2008 May;10(3):512-9. Epub 2007 Dec 20. PubMed PMID: 18097530.

8. Cavallini G, Modenini F, Vitali G. Open preliminary randomized prospectiveclinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie’s disease. Urology. 2007 May;69(5):950-4. PubMed PMID: 17482941.

9. Cavallini G. Male idiopathic oligoasthenoteratozoospermia. Asian J Androl. 2006 Mar;8(2):143-57. Review. PubMed PMID: 16491265

10. Cavallini G, Modenini F, Vitali G, Koverech A. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectiledysfunction after bilateral nerve-sparing radical retropubic prostatectomy.Urology. 2005 Nov;66(5):1080-5. PubMed PMID: 16286128.

11. Gianaroli L, Magli MC, Ferraretti AP, Tabanelli C, Trengia V, Farfalli V, Cavallini G. The beneficial effects of preimplantation genetic diagnosis for aneuploidy support extensive clinical application. Reprod Biomed Online. 2005 May;10(5):633-40. PubMed PMID: 15949222.

12. Gianaroli L, Magli MC, Cavallini G, Crippa A, Nadalini M, Bernardini L, Menchini Fabris GF, Voliani S, Ferraretti AP. Frequency of aneuploidy in sperm from patients with extremely severe male factor infertility. Hum Reprod. 2005 Aug;20(8):2140-52. Epub 2005 Apr 21. PubMed PMID: 15845594.

13. Cavallini G. Towards an evidence-based understanding of Peyronie’s disease. Int J STD AIDS. 2005 Mar;16(3):187-94; quiz 94-5. Review. PubMed PMID: 15829017.

14. Cavallini G, Ferraretti AP, Gianaroli L, Biagiotti G, Vitali G. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. J Androl. 2004 Sep-Oct;25(5):761-70; discussion 771-2. PubMed PMID: 15292108.

15. Cavallini G, Caracciolo S, Vitali G, Modenini F, Biagiotti G. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology. 2004 Apr;63(4):641-6. PubMed PMID: 15072869.

16. Cavallini G, Biagiotti G, Ferraretti AP, Gianaroli L, Vitali G. Medical therapy of oligoasthenospermia associated with left varicocele. BJU Int. 2003 Apr;91(6):513-8. PubMed PMID: 12656905.

17. Biagiotti G, Vitali G, Cavallini G. Dyspermia and testicular artery peak systolic velocity. Arch Ital Urol Androl. 2002 Dec;74(4):243-6. PubMed PMID:12508739.

18. Cavallini G, Biagiotti G, Koverech A, Vitali G. Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie’s disease. BJU Int. 2002 Jun;89(9):895-900. PubMed PMID: 12010235.

19. Biagiotti G, Cavallini G. Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie’s disease: a preliminary report. BJU Int. 2001 Jul;88(1):63-7. PubMed PMID: 11446848.

20. Cavallini G. (Editor) An Updating for Andrology. Transworld Research Company. Kerala, India, 2007.

21. Pezzoni F, Scroppo FI, Cavallini G. Author Reply. Urology. 2017 Jul;105:40-41.

22. Pezzoni F, Scroppo FI, Cavallini G. Differences in Cavernosal Artery Parameters According to Different Anatomic Sampling Locations During the Diagnosis of Vascular Erectile Dysfunction Using Duplex Ultrasound. Urology. 2017 Jul;105:33-41.

23. Cavallini G, Scroppo FI, Zucchi A.Peak systolic velocity thresholds of cavernosal penile arteries in patients with and without risk factors for arterial erectile deficiency. Andrology. 2016 Nov;4(6):1187-1192.

24. Favilla V, Russo GI, Zucchi A, Siracusa G, Privitera S, Cimino S, Madonia M, Cai T, Cavallini G, Liguori G, D’Achille G, Silvani M, Franco G, Verze P, Palmieri A, Torrisi B, Mirone V, Morgia G.Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie’s disease: preliminary results from a prospective, double-blinded, randomized study. Andrology. 2017 Jul;5(4):771-775.

25. Paulis G, Cavallini G, Barletta D, Turchi P, Vitarelli A, Fabiani A. Clinical and epidemiological characteristics of young patients with Peyronie’s disease: a retrospective study. Res Rep Urol. 2015 Jul 9;7:107-11.

26. Paulis G, Cavallini G, Giorgio GD, Quattrocchi S, Brancato T, Alvaro R. Long-term multimodal therapy (verapamil associated with propolis, blueberry, vitamin E and local diclofenac) on patients with Peyronie’s disease (chronic inflammation of the tunica albuginea). Results of a controlled study. Inflamm Allergy Drug Targets. 2013 Dec;12(6):403-408.

27. Paulis G, Cavallini G. Clinical evaluation of natural history of Peyronie’s disease: our experience, old myths and new certainties.Inflamm Allergy Drug Targets. 2013 Oct;12(5):341-8.

28. Cavallini G., Paulis G. Improvement of chronic Peyronie’s disease symptoms after diabetic compensation: a retrospective study. Urology. 2013 Apr;81(4):794-8.

29. Paulis G, Cavallini G, Brancato T, Alvaro R.Peironimev-Plus® in the treatment of chronic inflammation of tunica albuginea (Peyronie’s disease). results of a controlled study. Inflamm Allergy Drug Targets. 2013 Feb;12(1):61-7.

30. Cavallini G, Biagiotti G, Bolzon E. Multivariate analysis to predict letrozole efficacy in improving sperm count of non-obstructive azoospermic and cryptozoospermic patients: a pilot study. Asian J Androl. 2013 Nov;15(6):806-11.

31. Cavallini G, Scroppo FI, Zucchi A. Peak systolic velocity thresholds of cavernosal penile arteries in patients with and without risk factors for arterial erectile deficiency.Andrology. 2016 Nov;4(6):1187-1192.

32. Zucchi A, Costantini E, Cai T, Cavallini G, Liguori G, Favilla V, De Grande G, D’Achille G, Silvani M, Franco G, Palmieri A, Verze P, Mirone V. Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie’s Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study. Sex Med. 2016 Jun;4(2):e83-8.

33. Cavallini G., Maretti C. Unreliability of the Duplex Scan in Diagnosing Corporeal Venous Occlusive Disease in Young Healthy Men With Erectile Deficiency.Urology. 2018 Mar;113:91-98.

34. Maretti C., Cavallini G. The association of a probiotic with a prebiotic (Flortec, Bracco) to improve the quality/quantity of spermatozoa in infertile patients with idiopathic oligoasthenoteratospermia: a pilot study. Andrology. 2017 May;5(3):439-444.

35. Cavallini G, Beretta G, Biagiotti G, Mallus R, Maretti C, Pescatori E, Paulis G. Subsequent impaired fertility (with or without sperm worsening) in men who had fathered children after a left varicocelectomy: A novel population? Urol Ann. 2015 Jan-Mar;7(1):79-85.

36. Zucchi A, Cai T, Cavallini G, D’Achille G, Pastore AL, Franco G, Lepri L, Costantini E.Genital Lichen Sclerosus in Male Patients: A New Treatment with Polydeoxyribonucleotide. Urol Int. 2016;97(1):98-103.

37. Cavallini G.Resolution of erectile dysfunction after an andrological visit in a selected population of patients affected by psychogenic erectile dysfunction.Asian J Androl. 2017 Mar-Apr;19(2):219-222.

38. Cavallini G,Scroppo FI, Colpi GM. The clinical usefulness of a novel grading system for varicocoeles using duplex Doppler ultrasound examination based on postsurgical modifications of seminal parameters. Andrology.2018 Oct 24. doi: 10.1111/andr.12556. [Epub ahead of print].

39. Cavallini G, Scroppo FI. Relationships between biological aging and male reproductive monitors.Asian J.Anadrology, in stampa.

40. Cavallini G , Biagiotti G (2018) Phytotherapy of Male Hypoactive Sexual Desire of Psychogenic Origin. A Preliminary Study. Adv Androl Gynecol: AAG-104. DOI: 10.29011/AAG-104. 000004

41. Maretti C, Cavallini G.Topical application of eosin 2% with cloroxilenol 0.3%, propylen glycol 30% (Neomercurocromo) and colloidal silver: a new topical application for lichen sclerosus. International Journal of Pharma and Bio Sciences 2018 Oct; 9(4): (P) 168-173.

42. Maretti C, Cavallini G (2018) Hydroelectrophoresis for Transdermal Administration of Verapamile or of Hyaluronic Acid in Peyronie’s Disease: A Prospective, Open Label, Multicenter Study. Adv Androl Gynecol: AAG-103. DOI: 10.29011/AAG-103. 000003

Cavallini G. An Updating for Andrology. Transworld Research Company. Kerala, India, 2007. .
Cavallini, G., Paulis, G. (2015). Peyronie’s Disease. Berliner Springer Verlag. Heidelberg, Germania.
Cavallini, G. Beretta, G. (2015) Clinical Management of Male Infertility. Berliner Springer Verlag. Heidelberg. Germania.

Richiedi informazioni:

Campi obbligatori *

Il blog del Dott. Cavallini su:


Ferrara Via Mascheraio, 46
Tel. +39 0532/200847
Dott. Giorgio Cavallini
Via Mascheraio, 46 44121 Ferrara (Fe)
E-mail: - Tel. +39 0532/200847
Privacy Policy - P.Iva 01156940387
Hosting TITANKA! Spa © 2018